Alliancebernstein L.P. Ginkgo Bioworks Holdings, Inc. Transaction History

Alliancebernstein L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.28 - $1.16 $106,023 - $439,240	-378,656 Reduced 82.33%	81,294 $26,000
Q1 2024 May 14, 2024	BUY	$1.06 - $1.67 $2,363 - $3,724	2,230 Added 0.49%	459,950 $533,000
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $62,982 - $89,474	49,986 Added 12.26%	457,720 $773,000
Q3 2023 Nov 14, 2023	SELL	$1.61 - $2.54 $5,282 - $8,333	-3,281 Reduced 0.8%	407,734 $737,000
Q2 2023 Aug 15, 2023	BUY	$1.14 - $1.95 $211,196 - $361,257	185,260 Added 82.06%	411,015 $764,000
Q1 2023 May 15, 2023	SELL	$1.2 - $2.19 $12,241 - $22,340	-10,201 Reduced 4.32%	225,755 $300,000
Q4 2022 Feb 14, 2023	BUY	$1.63 - $3.52 $60,329 - $130,282	37,012 Added 18.6%	235,956 $398,000
Q3 2022 Nov 15, 2022	SELL	$0.73 - $3.74 $1,387 - $7,109	-1,901 Reduced 0.95%	198,944 $621,000
Q2 2022 Aug 15, 2022	BUY	$2.2 - $4.2 $441,859 - $843,549	200,845 New	200,845 $478,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.